EQ Health Acquisition Corp. announced that in connection with the IPO, Mr. Lewis N. Little, Jr., Mr. Andrew Beckman, Mr. William W. Burke, Ms. Molly Cate, and Mr. Clarke Heidrick were appointed to the board of directors of the Company. Mr. Burke, Ms. Cate, and Mr. Heidrick are independent directors. Mr. Burke, Ms. Cate, and Mr. Heidrick were also appointed to the Board's Audit Committee, with Mr. Burke serving as chair of the Audit Committee; Mr. Burke, Ms. Cate, and Mr. Heidrick were appointed to the Board's Compensation Committee, with Ms. Cate serving as chair of the Compensation Committee; and Mr. Burke, Ms. Cate, and Mr. Heidrick were appointed to the Nominating and Corporate Governance Committee, with Mr. Heidrick serving as chair of the Nominating and Corporate Governance Committee. Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consists of Mr. Beckman and will expire at the Company's first annual meeting of stockholders; the term of office of the second class of directors, Class II, consists of Mr. Heidrick and Ms. Cate, and will expire at the company's second annual meeting of stockholders; and the term of office of the third class of directors, Class III, consists of Messrs. Little and Burke and will expire at the company's third annual meeting of stockholders.